Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its ability to enhance metabolic stability and binding affinity in drug molecules. Its trifluoromethylphenyl group contributes to improved lipophilicity and bioavailability, making it valuable in designing CNS-active agents and anti-inflammatory drugs. Also employed in research for novel receptor antagonists and enzyme inhibitors.